
Quoin Pharmaceuticals, Ltd. — Investor Relations & Filings
Quoin Pharmaceuticals, Ltd. is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of therapeutic products for rare and orphan diseases. The company's lead product candidate, QRX003, is in development for the treatment of Netherton Syndrome, a rare hereditary skin disorder. Quoin utilizes the proprietary Invisicare delivery technology, for which it holds exclusive rights for orphan rare skin disease applications. The company's strategy involves establishing exclusive international marketing and distribution partnerships to augment its own commercial infrastructure in the US, Europe, and Japan, ensuring its products reach patients globally.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Quoin Pharmaceuticals, Ltd. (0001671502) (Filer) | 2026-05-07 | English | |
| 10-K - Quoin Pharmaceuticals, Ltd. (0001671502) (Filer) | 2026-03-26 | English | |
| 8-K - Quoin Pharmaceuticals, Ltd. (0001671502) (Filer) | 2026-03-26 | English | |
| SCHEDULE 13G Filing | 2026-02-17 | English | |
| SCHEDULE 13G Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-11 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 43281164 | 10-Q - Quoin Pharmaceuticals, Ltd. (0001671502) (Filer) | 2026-05-07 | English | ||
| 33052242 | 10-K - Quoin Pharmaceuticals, Ltd. (0001671502) (Filer) | 2026-03-26 | English | ||
| 33049202 | 8-K - Quoin Pharmaceuticals, Ltd. (0001671502) (Filer) | 2026-03-26 | English | ||
| 31223504 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 31223476 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 31223477 | SCHEDULE 13G/A Filing | 2026-02-11 | English | ||
| 31223607 | 4 Filing | 2026-02-06 | English | ||
| 31223571 | SCHEDULE 13G/A Filing | 2026-02-06 | English | ||
| 31223528 | 4 Filing | 2026-02-06 | English | ||
| 31223434 | 4 Filing | 2026-02-06 | English | ||
| 31223421 | 4 Filing | 2026-02-06 | English | ||
| 31223413 | 4 Filing | 2026-02-06 | English | ||
| 31223406 | 4 Filing | 2026-02-06 | English | ||
| 31223405 | 4 Filing | 2026-02-06 | English | ||
| 31223401 | 4 Filing | 2026-02-06 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
|
Adaptogenics Health Corp.
Formulates and distributes functional mushroom and adaptoge…
|
ADPT | CA | Manufacturing |
|
Adastra Holdings
Manufacturer and supplier of ethnobotanical and processed c…
|
XTRX | CA | Manufacturing |
|
ADBIOTECH Co.,Ltd.
Develops IgY-based immune antibodies as alternatives to vac…
|
179530 | KR | Manufacturing |
|
ADC Therapeutics SA
Commercial-stage biotech developing antibody-drug conjugate…
|
ADCT | US | Manufacturing |
|
Addex Therapeutics Ltd.
Clinical-stage biopharma developing allosteric modulators f…
|
ADXN | CH | Manufacturing |
|
Adeshwar Meditex Limited
Manufacturer and exporter of medical disposables, surgical …
|
543309 | IN | Manufacturing |
|
ADIAL PHARMACEUTICALS, INC.
A clinical-stage biopharma developing genetically targeted …
|
ADIL | US | Manufacturing |
|
Adicet Bio, Inc.
Develops allogeneic gamma delta T cell therapies for cancer…
|
ACET | US | Manufacturing |
|
ADIM
Develops and manufactures human vaccines and biologics for …
|
4142 | TW | Manufacturing |
Quoin Pharmaceuticals, Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35443/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35443 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35443 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35443 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35443}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Quoin Pharmaceuticals, Ltd. (id: 35443)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.